Clinical trials
Infection, Hospital clinical trials
Below are recruiting infection, hospital clinical trials, each written for real people, not researchers. We’re tracking 398 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06856967Recruiting
Nirsevimab for RSV in infants under 1 year
This study looks at whether the drug nirsevimab can reduce hospitalizations caused by RSV (a common respiratory virus) in babies under 1 year old. If your baby has a lung infection like bronchiolitis or pneumonia, this trial may help understand how well the medicine works.
Arezzo, ArezzoAges Up to 1 year - NCT06634940Recruiting
Tracking antibiotic resistance in cirrhosis infections
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
Buenos Aires, Buenos Aires F.D.Ages 17 years+ - NCT05914779Recruiting
Early antibiotics after out-of-hospital cardiac arrest
This study looks at whether starting antibiotics soon after an out-of-hospital cardiac arrest helps patients who are unlikely to have an infection. Antibiotics may prevent or treat infection-related complications, but only if certain infection and health conditions are met.
Doha, Baladiyat ad DawhahAges 18 years+ - NCT07004049RecruitingPhase 4
Testing combinations for resistant Gram-negative infections
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Brisbane, QueenslandAges 18 years+ - NCT07635368Recruiting
Blood Markers in Newborns With CMV Infection
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
CopenhagenAges birth–4 weeks - NCT07299565Recruiting
Knee infection trial: drug levels after spacer surgery
This trial studies how antibiotics reach the knee joint after a temporary antibiotic spacer is placed. It may help improve treatment for people having two-stage surgery for a knee prosthesis infection.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07299591Recruiting
Antibiotic levels in hip infection spacer study
This study is testing a new way to measure how well antibiotics reach the infected area around a hip implant during a two-stage replacement surgery. If you are already planning this surgery, researchers want to see if the levels of antibiotics in the spacer are high enough to fight the infection.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07536035Recruiting
Comparing Hospital Care Pathways for Acute Medical Illness
This study compares two different hospital care pathways for adults admitted with acute medical emergencies like infections, falls, or COPD flare-ups. The goal is to see which pathway provides more appropriate and effective care.
SingaporeAges 21 years+ - NCT06775808Recruiting
Understanding eye infections through DNA testing
This study looks at eye infections by testing leftover fluid or tissue samples to find all possible germs, including viruses, bacteria, and fungi. It may help doctors better understand what causes different eye infections and improve treatment.
Shanghai, Shanghai MunicipalityAges Any age - NCT07303101Recruiting
One-stage replacement for candida joint infections
This study looks at whether a single surgery to replace a hip or knee joint is effective for infections caused by Candida fungus. It may help people who need a joint replacement due to this type of infection.
StrasbourgAges 18 years+ - NCT05264259Recruiting
Monoclonal antibodies for BK virus infection
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
StrasbourgAges 18 years+ - NCT07395518Enrolling by invitation
Drain placement in c-section for women with thick belly fat
This trial tests if placing a small drain under the skin during a cesarean section reduces surgical site infections in women with a belly fat thickness of 4 cm or more. It may help prevent infections and improve recovery.
Chon Buri, Changwat Chon BuriAges 18 years+ - NCT04098133Recruiting
Tracking germs that resist key antibiotics in Swiss hospitals
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
BaselAges 18 years+ - NCT05475574Recruiting
Stopping extra cleaning for some resistant bacteria in geriatrics
This trial looks at whether stopping extra “contact precautions” (special measures to prevent spread) is safe for older hospital patients who carry a certain type of hard-to-treat gut bacteria. It may reduce unnecessary isolation and improve comfort, while still aiming to prevent infections.
MetzAges 65 years+ - NCT04767945Recruiting
Cirrhosis patient hospital registry
This study keeps a record of people who have liver cirrhosis and were admitted to the hospital after a worsening event. It may help doctors better understand what leads to hospital stays and improve future care.
Banská BystricaAges 19 years+ - NCT06106698Recruiting
Washed microbiota transplant for C. diff infection
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
Nanjing, JiangsuAges 3–100 - NCT06462235RecruitingPhase 2
Testing a new antibiotic for hospitalized babies with infection
This study tests a new antibiotic called aztreonam-avibactam (ATM-AVI) for treating serious bacterial infections in hospitalized babies under 9 months old. The goal is to see if it's safe and works well.
Orange, CaliforniaAges Up to 9 months - NCT07345923Recruiting
Rectal swab test to predict resistant infections in ICU
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
StrasbourgAges 18 years+ - NCT07089186RecruitingPhase 3
Study of meropenem and pralurbactam for certain antibiotic-resistant infections
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
ShanghaiAges 18–80 - NCT06910878Recruiting
Studying resistant bacteria in urine infections
This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.
StrasbourgAges 18 years+ - NCT07684300Recruiting
Testing a faster infection test to improve antibiotic use
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
Elche, AlicanteAges 18 years+ - NCT07343167Recruiting
Study of factors linked to death in certain strep blood infections
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
StrasbourgAges 18 years+ - NCT07343089Recruiting
Study of Lyme disease during anti-CD20 treatment in France
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
StrasbourgAges 1 year+ - NCT07335965Recruiting
Recurring Lyme disease after travel
This study looks at people who have had Lyme disease more than once after traveling abroad. It aims to understand the patterns of the infection and why it comes back.
StrasbourgAges 1 year+
Hear when a new Infection, Hospital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection, hospital?
- Yes. Clin2 currently lists 398 recruiting infection, hospital studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection, hospital trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection, hospital trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.